(PharmaNewsWire.Com, March 21, 2017 ) According to the report North America Antibodies, published by Market Data Forecast, the North America market projected to reach USD 82.177 billion by 2021, at a CGSR of 12.45% from 2016 to 2021.
Antibodies (Abs) are also known as an immunoglobulin (Ig) that are large, Y-shaped protein produced by plasma cells which are used by the immune system to identify, detect and neutralize pathogens such as bacteria and Viruses. They recognize a unique part of foreign target known as an antigen.
Y shaped tip of an antibody helps to bind with the antigens. So with this binding mechanism, an antibody can tag a microbe for attack by other parts of the immune system, or it can neutralize its target directly. Effective harmonization of product approval, development, and registration guidelines in some of the major markets, such as United States can speed up the research and development of antibody related products. North America Antibodies market is driven by continuous development of innovative products, rise in chronic illnesses owing to population shift and increasing longevity, increased adoption rate to therapeutic antibodies in cost-sensitive markets, rapid approval by regulatory authorities for breakthrough therapies, and adoption of diagnostic antibodies. Companies are practicing various strategies, like expansion of products indications to sustain the dynamically growing market. Side effects associated with antibodies treatment and high cost of treatment are the restraints that are affecting the growth of the market.
The North America Antibodies market is segmented as following: Based on Product Type: Monoclonal Antibodies Murine Chimeric Humanized Human Polyclonal Antibodies Type I Type II Type III Type IV Type V Type VI Type VII Type VIII Antibody-Drug Complexes Immunogen Technology Seattle Genetics Technology Immunomedics Technology Based on Indication: Cancer Autoimmune Diseases Infectious Diseases Cardiovascular Diseases CNS Disorders Others (Inflammatory, Microbial Diseases, & Other) Based on End User: Hospitals/Clinics Research Institute Diagnostic Laboratories Based on Application: Medical Experimental Western Blot ELISA Radioimmune Assays Immunofluorescence Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)
The key players in North America Antibodies Market are Abbott Diagnostics, Novartis AG, ThermoFisher Scientific Inc., Pfizer Inc., Bristol-Myers Squibb, Eli Lilly and company, A.G. Scientific, Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc.
The North America Antibodies Market study offers the following deliverables: North America, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
